TC BioPharm Provides Shareholder Update; Signed Two Separate Non-Binding LOIs For Acquisitions In Cell Therapy Modalities Outside Core TCB008
TC BioPharm Provides Shareholder Update; Signed Two Separate Non-Binding LOIs For Acquisitions In Cell Therapy Modalities Outside Core TCB008
TC BioPharm提供股東更新；簽署了兩份獨立的非約束性意向書，用於收購TCB008核心以外的細胞療法模式。
TC BioPharm Provides Shareholder Update; Signed Two Separate Non-Binding LOIs For Acquisitions In Cell Therapy Modalities Outside Core TCB008
TC BioPharm提供股東更新；簽署了兩份獨立的非約束性意向書，用於收購TCB008核心以外的細胞療法模式。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間